HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raymond A Dwek Selected Research

Acute-Phase Proteins (Acute-Phase Protein)

12/2008A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
1/2008Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.
12/2007Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raymond A Dwek Research Topics

Disease

17Infections
01/2020 - 04/2002
15Neoplasms (Cancer)
01/2014 - 04/2003
8Diarrhea
06/2010 - 03/2002
5Gaucher Disease (Gaucher's Disease)
01/2014 - 01/2002
5Hepatitis B
10/2010 - 01/2002
5Sandhoff Disease (Sandhoff's Disease)
03/2009 - 08/2002
5Disease Progression
12/2008 - 11/2004
5Uveal melanoma
07/2007 - 11/2004
4Hepatitis C
01/2012 - 02/2004
4Fibrosis (Cirrhosis)
01/2012 - 10/2007
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2012 - 10/2007
4Breast Neoplasms (Breast Cancer)
12/2008 - 01/2005
4Neoplasm Metastasis (Metastasis)
12/2008 - 12/2005
4Inflammation (Inflammations)
12/2007 - 10/2004
4Infertility (Sterility)
11/2007 - 12/2002
4Rheumatoid Arthritis
01/2007 - 10/2004
3Virus Diseases (Viral Diseases)
01/2020 - 01/2002
3Gangliosidoses (Gangliosidosis)
04/2010 - 08/2004
3GM2 Gangliosidoses (GM2 Gangliosidosis)
04/2010 - 08/2002
3Melanoma (Melanoma, Malignant)
07/2003 - 05/2002
2COVID-19
12/2022 - 01/2022
2Sepsis (Septicemia)
11/2021 - 12/2007
2Human Influenza (Influenza)
01/2020 - 11/2008
2Pathologic Processes
01/2014 - 12/2002
2Hepatocellular Carcinoma (Hepatoma)
12/2011 - 04/2006
2Cardiovascular Diseases (Cardiovascular Disease)
10/2010 - 10/2009
2Atherosclerosis
10/2009 - 09/2004
2Acquired Immunodeficiency Syndrome (AIDS)
10/2008 - 04/2007
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2008 - 03/2007
2Autoimmune Diseases (Autoimmune Disease)
02/2008 - 04/2006
2Carcinoma (Carcinomatosis)
01/2008 - 04/2007
2Ovarian Neoplasms (Ovarian Cancer)
01/2008 - 12/2007
2Chronic Hepatitis C
08/2007 - 09/2002
2Prostatic Neoplasms (Prostate Cancer)
02/2006 - 06/2003
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
10/2005 - 11/2004
2Experimental Melanoma
03/2005 - 07/2003
1Coinfection
11/2021
1Dengue (Dengue Fever)
05/2016
1Bone Diseases (Bone Disease)
06/2015
1Cytokine Release Syndrome
04/2013
1Severe Dengue
04/2013
1Viremia
04/2013

Drug/Important Bio-Agent (IBA)

20Polysaccharides (Glycans)IBA
01/2014 - 04/2003
16Glycoproteins (Glycoprotein)IBA
08/2010 - 03/2002
13Proteins (Proteins, Gene)FDA Link
01/2012 - 12/2002
11Antiviral Agents (Antivirals)IBA
01/2020 - 04/2002
11Biomarkers (Surrogate Marker)IBA
01/2012 - 01/2005
9miglustat (Zavesca)FDA Link
10/2008 - 05/2002
7Immunoglobulin G (IgG)IBA
05/2008 - 10/2004
7SugarsIBA
11/2007 - 05/2002
5CytokinesIBA
11/2021 - 04/2006
5Pharmaceutical PreparationsIBA
01/2014 - 10/2005
5Imino SugarsIBA
11/2007 - 01/2002
5EnzymesIBA
10/2005 - 01/2002
5Monophenol Monooxygenase (Tyrosinase)IBA
04/2005 - 05/2002
4GlucosidasesIBA
05/2016 - 03/2002
4GlycosphingolipidsIBA
06/2015 - 11/2002
4Complement System Proteins (Complement)IBA
01/2012 - 10/2004
4Ribavirin (Virazole)FDA LinkGeneric
05/2008 - 09/2002
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2006 - 12/2002
3GlycolipidsIBA
01/2014 - 06/2004
3LipidsIBA
01/2012 - 08/2004
3Liposomes (Liposome)IBA
10/2010 - 05/2002
3Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2008 - 12/2007
3HaptoglobinsIBA
12/2008 - 10/2007
3InterferonsIBA
05/2008 - 09/2002
3Immunoglobulins (Immunoglobulin)IBA
03/2008 - 10/2007
3AntigensIBA
02/2008 - 07/2003
2AntibodiesIBA
01/2022 - 02/2008
2SaltsIBA
01/2020 - 05/2016
2Interferon Receptors (Interferon Receptor)IBA
05/2016 - 04/2013
2Viral RNAIBA
04/2013 - 05/2008
2CholesterolIBA
12/2011 - 10/2010
2CarbohydratesIBA
04/2010 - 06/2003
2beta-N-AcetylhexosaminidasesIBA
04/2010 - 03/2009
2G(M2) Ganglioside (Ganglioside GM2)IBA
04/2010 - 11/2004
2Immunoglobulin M (IgM)IBA
03/2008 - 03/2007
2LectinsIBA
02/2008 - 12/2006
2Galactose (Galactopyranose)FDA LinkGeneric
02/2008 - 08/2004
2Sialyl Lewis X AntigenIBA
01/2008 - 04/2003
2Transferrin (beta 2 Transferrin)IBA
01/2008 - 06/2006
2Ribonucleases (Ribonuclease)IBA
04/2007 - 04/2003
2Glycoside Hydrolase InhibitorsIBA
04/2007 - 04/2006
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
12/2006 - 10/2004
2Tumor Biomarkers (Tumor Markers)IBA
02/2006 - 04/2003
2Prostate-Specific Antigen (Semenogelase)IBA
02/2006 - 06/2003
2migalastatIBA
04/2005 - 08/2004
2Melanins (Melanin)IBA
03/2005 - 05/2002
2N-nonyl-1-deoxynojirimycinIBA
02/2004 - 04/2002
1Neutralizing AntibodiesIBA
01/2022
1SARS-CoV-2 spike proteinIBA
01/2022
1SteroidsIBA
11/2021
1glucosidase IIBA
01/2020
11-Deoxynojirimycin (1 Deoxynojirimycin)IBA
01/2020
1Investigational DrugsIBA
05/2016
1celgosivirIBA
03/2016
1Viral VaccinesIBA
01/2014
1Apolipoprotein L1IBA
01/2012

Therapy/Procedure

12Therapeutics
12/2022 - 09/2002
2Oral Administration
04/2005 - 12/2002